by Tamiflu (Oseltamivir Phosphate), commonly known as Tamiflu, is an antiviral drug used to treat and prevent influenza A and influenza B (flu). Tamiflu works by preventing the flu virus from spreading inside the body. It is available as an oral capsule and is taken twice a day for five days. The global Tamiflu market witnessed significant growth during the COVID-19 pandemic due to rising demand for antiviral drugs. Tamiflu is prescribed to treat patients suffering from influenza whose symptoms overlap with those of COVID-19.
The global Tamiflu (Oseltamivir Phosphate) Market is estimated to be valued at US$ 464.4 Mn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Rising postpandemic demand for antiviral drugs is expected to drive the growth of the Tamiflu (Oseltamivir Phosphate) market over the forecast period. The COVID-19 pandemic highlighted the importance of having effective antiviral treatments for respiratory viral infections. Though Tamiflu is used to treat influenza specifically, it received increased attention during the pandemic due to overlapping flu and COVID-19 symptoms. This has resulted in growing awareness about the role of antiviral drugs in pandemic preparedness. As a result, demand for established antiviral drugs like Tamiflu is expected to remain high even post the pandemic.
Additionally, recurring influenza outbreaks every year fuels the need for effective antiviral medications for flu treatment. The widespread annual influenza epidemics and sporadic pandemics continue to burden healthcare systems worldwide. Thus, growing disease burden of influenza acts as a major driver for the antiviral drugs market over the long run.
Segment Analysis
The global tamiflu (oseltamivir phosphate) market is dominated by the hospitals end-use segment. Hospitals account for over 60% of the total tamiflu sales globally. The high segment share can be attributed to the availability of advanced healthcare services along with medical expertise to treat infectious diseases including influenza across hospitals.
PEST Analysis
Political: Governments across countries have imposed certain regulations pertaining to vaccine production and distribution. This helps ensure adequate supply of approved drugs to treat influenza.
Economic: Rising healthcare spending coupled with growing population affected by influenza infections is fueling the demand for drugs like tamiflu globally. The average per capita healthcare spending is expected to increase substantially.
Social: Growing awareness regarding influenza and availability of effective treatment options is encouraging more patients to opt for drugs like tamiflu. This is positively impacting the market growth.
Technological: Advancements in drug delivery technologies has allowed development of innovative formulations of tamiflu including orally disintegrating tablets and suspensions for pediatric use. This has enhanced patient compliance.
Key Takeaways
The Global Tamiflu (Oseltamivir Phosphate) Market Size is expected to witness high growth over the forecast period supported by rising influenza cases and increasing healthcare spending globally. The global Tamiflu (Oseltamivir Phosphate) Market is estimated to be valued at US$ 464.4 Mn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030.
Regional analysis: North America accounts for the largest share currently in the global tamiflu market due to presence of major players and strong healthcare infrastructure. However, Asia Pacific is expected to emerge as the fastest growing regional market owing to improving access to healthcare in the region.
Key players: Key players operating in the tamiflu (oseltamivir phosphate) market are HCA Healthcare, Ascension Health, Kaiser Permanente, Mayo Clinic. HCA Healthcare captured the highest market share in 2021 due to its diversified healthcare service portfolio and geographical reach across the US.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
